Centre extends medical devices PLI scheme by 8 yrs, eases eligibility norms
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓The Centre extended the medical devices PLI scheme to FY36 to boost domestic manufacturing.
- ✓Officials said, "The applicants can submit applications through an online portal, which will be operational in the next ten days." The government also eased eligibility norms, including lower investment requirements, to help companies make high-end equipment.
Story at a Glance
- Category
- Indian Markets
- Reported By
- Business Standard
- Reading Speed
- 4 Minute(s)
- Market Focus
- India Economy
The Centre has extended the medical devices PLI scheme to FY36 and eased eligibility norms to encourage domestic manufacturing of critical components and high-end medical equipment, including MRI and PET-CT machines.
The Department of Pharmaceuticals (DoP) has extended the production-linked incentive (PLI) scheme to promote domestic manufacturing of medical devices by eight years to the financial year 2035-36.
Calling for fresh applications under the extended scheme, the DoP said that an outlay of approximately ₹2,700 crore available under the existing scheme will be utilised for the purpose.
"The applicants can submit applications through an online portal, which will be operational in the next ten days," officials aware of the matter said.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Business Standard
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.